Contact this trialFirst, we need to learn more about you.
Anti-tumor agent
Enasidenib for Sinonasal and Skull Base Cancer
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a drug called enasidenib to see if it can help people with rare cancers of the nasal cavity or skull base. These cancers often have a specific gene mutation called IDH
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service